Rheumatoid arthritis(RA)patients face significant psychological challenges alongside physical symptoms,necessitating a comprehensive understanding of how psychological vulnerability and adaptation patterns evolve thro...Rheumatoid arthritis(RA)patients face significant psychological challenges alongside physical symptoms,necessitating a comprehensive understanding of how psychological vulnerability and adaptation patterns evolve throughout the disease course.This review examined 95 studies(2000-2025)from PubMed,Web of Science,and CNKI databases including longitudinal cohorts,randomized controlled trials,and mixed-methods research,to characterize the complex interplay between biological,psychological,and social factors affecting RA patients’mental health.Findings revealed three distinct vulnerability trajectories(45%persistently low,30%fluctuating improvement,25%persistently high)and four adaptation stages,with critical intervention periods occurring 3-6 months postdiagnosis and during disease flares.Multiple factors significantly influence psychological outcomes,including gender(females showing 1.8-fold increased risk),age(younger patients experiencing 42%higher vulnerability),pain intensity,inflammatory markers,and neuroendocrine dysregulation(48%showing cortisol rhythm disruption).Early psychological intervention(within 3 months of diagnosis)demonstrated robust benefits,reducing depression incidence by 42%with effects persisting 24-36 months,while different modalities showed complementary advantages:Cognitive behavioral therapy for depression(Cohen’s d=0.68),mindfulness for pain acceptance(38%improvement),and peer support for meaning reconstruction(25.6%increase).These findings underscore the importance of integrating routine psychological assessment into standard RA care,developing stage-appropriate interventions,and advancing research toward personalized biopsychosocial approaches that address the dynamic psychological dimensions of the disease.展开更多
目的:评价中医内治法与甲氨蝶呤(methotrexate,MTX)联合使用治疗寒湿痹阻型类风湿关节炎(rheumatoid arthritis,RA)的临床疗效与安全性。方法:检索中国知网、重庆维普、万方数据、中国生物医学文献数据库、Web of Science、PubMed、EMb...目的:评价中医内治法与甲氨蝶呤(methotrexate,MTX)联合使用治疗寒湿痹阻型类风湿关节炎(rheumatoid arthritis,RA)的临床疗效与安全性。方法:检索中国知网、重庆维普、万方数据、中国生物医学文献数据库、Web of Science、PubMed、EMbase数据库及Cochrane图书馆8个中外文数据库中关于中药内治法联合MTX治疗寒湿痹阻型RA的随机对照试验(randomized controlled trials,RCTs),时间从建库截止至2023年11月。由2名人员根据纳入与排除标准,独立进行文献筛选、数据提取、质量评价、并交叉核对结果,采用RevMan 5.3软件进行Meta分析。结果:共纳入15个RCTs,共1356例寒湿痹阻型类风湿关节炎患者。Meta分析显示,在有效率升高(RR=1.20,95%CI:1.14~1.27,P<0.00001)、晨僵时间(SMD=0.75,95%CI:0.59~0.90,P<0.00001)、肿胀关节数(MD=0.59,95%CI:0.50~0.68,P<0.00001)、压痛关节数(MD=0.71,95%CI:0.58~0.84,P<0.00001)、ESR(MD=6.16,95%CI:5.02~7.31,P<0.00001)、CRP(MD=1.48,95%CI:0.71~2.25,P=0.0002)、不良反应(RR=0.45,95%CI:0.31~0.65,P<0.0001)方面的影响试验组优于对照组,差异有统计学意义;对TNF-α(MD=-0.17,95%CI:-1.41~1.08,P=0.79)的影响差异无统计学意义。其中13篇RCT关注了不良反应,有7个研究详细报告了不良反应发生率,所有文献均未见严重的不良反应报道。结论:基于当前临床证据初步得出,中医内治法联合甲氨蝶呤治疗寒湿痹阻型RA的有效性和安全性可能优于单纯使用MTX治疗,但尚需要高质量的RCT验证。展开更多
基金Supported by Chongqing Health Commission and Chongqing Science and Technology Bureau,No.2023MSXM182。
文摘Rheumatoid arthritis(RA)patients face significant psychological challenges alongside physical symptoms,necessitating a comprehensive understanding of how psychological vulnerability and adaptation patterns evolve throughout the disease course.This review examined 95 studies(2000-2025)from PubMed,Web of Science,and CNKI databases including longitudinal cohorts,randomized controlled trials,and mixed-methods research,to characterize the complex interplay between biological,psychological,and social factors affecting RA patients’mental health.Findings revealed three distinct vulnerability trajectories(45%persistently low,30%fluctuating improvement,25%persistently high)and four adaptation stages,with critical intervention periods occurring 3-6 months postdiagnosis and during disease flares.Multiple factors significantly influence psychological outcomes,including gender(females showing 1.8-fold increased risk),age(younger patients experiencing 42%higher vulnerability),pain intensity,inflammatory markers,and neuroendocrine dysregulation(48%showing cortisol rhythm disruption).Early psychological intervention(within 3 months of diagnosis)demonstrated robust benefits,reducing depression incidence by 42%with effects persisting 24-36 months,while different modalities showed complementary advantages:Cognitive behavioral therapy for depression(Cohen’s d=0.68),mindfulness for pain acceptance(38%improvement),and peer support for meaning reconstruction(25.6%increase).These findings underscore the importance of integrating routine psychological assessment into standard RA care,developing stage-appropriate interventions,and advancing research toward personalized biopsychosocial approaches that address the dynamic psychological dimensions of the disease.
